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Down syndrome (DS) and Fetal Alcohol Syndrome (FAS) are two 
leading causes of birth defects with phenotypes ranging from 
cognitive impairment to craniofacial abnormalities. These 
syndromes have an estimated occurrence of 1/750 and 1/1000 
live births, respectively. While DS originates from the trisomy of 
human chromosome 21 and FAS from excess alcohol 
consumption, many of the defining characteristics for these two 
disorders are stunningly similar. Our research of the published 
literature has identified more than 20 similarities in DS and FAS 
phenotypes including precise craniofacial and neurological 
abnormalities. We hypothesize that the similar phenotypes in 
these two syndromes are caused by disruptions in common 
molecular and cellular pathways. To test our hypothesis we are 
examining morphometric, genetic, and cellular phenotypes 
during development of DS and FAS mouse models. Our 
preliminary evidence indicates that during early development, 
expression of Dyrk1a and Rcan1 (two genes found in three 
copies in individuals with DS) is dysregulated in the craniofacial 
and neurological precursors of both DS and FAS as compared to 
normal control embryos.  Using immuocytochemistry, we are 
analyzing cellular properties of neurological development in DS 
embryos and comparing deficiencies found between trisomic and 
normal mice to those found in FAS embryos at similar stages. 
These results will further define molecular and cellular alterations 
leading to DS and FAS phenotypes and provide mechanisms to 
target for potential pharmacotherapy. 
 
